In ovarian carcinoma, CDK20 knockdown in cells led to G1 phase cell cycle arrest, and CDK20 overexpression caused cell proliferation in vitro and tumor growth in vivo, and is positively correlated with an advanced stage of ovarian cancer. Here, CDK20 is linked to neoplasm.